COVID-19 vaccination in Nepal
 | This article needs additional citations for verification. (May 2021) |
| Date | 27 January 2021 – present (146 days ago) |
|---|---|
| Location | Nepal |
| Cause | COVID-19 pandemic |
| Target | Immunisation of Nepalese against COVID-19 |
| Organised by | Government of Nepal |
| Participants |
|
| Outcome |
|
| Website | www vaccine |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million vaccines were provided by India as grant while Nepal brought 1 million doses from Serum Institute of India while government decided to buy next 1 million soon. The delivery of the first consignment was swift, as 1 million doses arrived on 21 February. Nepal granted emergency use approval to Sinopharm's Vero Cell (BBIBP-CorV) on 15 February. China had promised 800,000 doses of the Sinopharm vaccine under grant assistance. The Chinese vaccine arrived in Nepal on 29 March. Nepal brought next 1 million from Serum Institute of India while the ongoing buying process was halted due to temporary ban of India on export of vaccine. Talks with many vaccine manufacturing countries, mainly the US and China, is going on for now to buy more shots of vaccine soon.[1]
Different stages[edit]
The campaign was launched with the 1 million doses India had provided under grant assistance. At that time, the virus had claimed 2,017 lives and infected 270,092 across the country. Around 430,000 frontline workers–health workers, supporting staffers at health facilities, female community health volunteers, security personnel, sanitation workers, elderly people living in care homes, and prisoners–were listed as priority groups for vaccination. After the first round of the first phase was completed, the government said journalists and diplomatic staff could take the jabs. When the government announced that the first phase was completed on 5 March, as many as 438,000 had received their first dose.[citation needed]
The day the second phase of vaccination was started 348,000 doses of Covishield arrived in Nepal under the World Health Organisation-backed COVAX facility. The government said all the citizens above 65 years of age would be inoculated. The public response was quite encouraging. In the second phase, around 1.3 million people were inoculated across the country.[citation needed]
Vaccines in order[edit]
Currently, the vaccines approved by government of Nepal for emergency use are:
| Vaccine | Approval | Deployment |
|---|---|---|
| Oxford–AstraZeneca |  Yes[2]
|
Yes
|
| Sinopharm | Yes[3]
|
Yes
|
| Covaxin | Yes[4]
|
 No
|
| Sputnik V | Yes[5]
|
No
|
| Sinovac | Yes[6]
|
No
|
References[edit]
- ^ "Nepal's vaccination status". The Kathmandu Post. 12 May 2021.
- ^ "Nepal approves AstraZeneca COVID vaccine for emergency use – government statement". Reuters. 15 January 2021. Retrieved 31 May 2021.
- ^ "China's Shinopharm vaccine gets emergency use authorisation in Nepal". The Kathmandu Post. Retrieved 31 May 2021.
- ^ "Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN". Reuters. 19 March 2021. Retrieved 31 May 2021.
- ^ "Nepal approves Russia's Sputnik V COVID-19 vaccine". Reuters. 20 April 2021. Retrieved 31 May 2021.
- ^ "Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine". kathmandupost.com. Retrieved 7 June 2021.
